SanazNoelleGhafouriMD

Oncology • Woodland, CA

Hematologic Oncology

ucla internal medicine

Join to view full profile

Dr. Ghafouri is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ghafouri's full profile

Already have an account?

Office
515 Fairchild Ct
Woodland, CA 95695
Phone+1 530-668-2600

Fax+1 530-669-3661

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2017 - 2019
George Washington University School of Medicine and Health SciencesClass of 2016

Certifications & Licensure

CA State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

14 citations
Real-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.
Sanaz Ghafouri, Kathleen Fenerty, Gary J. Schiller, Sven de Vos, Herbert Eradat
Clinical Lymphoma, Myeloma & Leukemia. 2021-07-19
25 citations
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.
Sarah M Larson, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek
Cancer Discovery. 2023-03-01
13 citations
Immune reconstitution inflammatory syndrome, human herpesvirus 8 viremia, and HIV-associated multicentric Castleman disease
Marc O. Siegel, Sanaz Ghafouri, Ravi K. Ajmera, Gary L. Simon
International Journal of Infectious Diseases. 2016-07-01

Abstracts/Posters

Outcomes Related to Intravenous Fluid Administration in Sickle Cell Patients during Vaso-Occlusive Crisis
Sanaz Ghafouri, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Evaluating a New Bispecific CAR T-cell Therapy for B-cell LymphomasMay 1st, 2021
New CAR T Approach Minimizes Resistance, Helps Avoid Relapse in Non-Hodgkin's B-cell LymphomaApril 10th, 2021